Terms: = Lymphoma AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Prognosis
3 results:
1. t(10;12)(q24;q15): A new cytogenetic marker in hematological malignancies.
Bernués M; González T; Corchete LA; Santos S; Durán MA; López-Andrade B; Riso LL; Martínez-Serra J; Ramos R; Iglesias J; Royo I; Rosell J
Cancer Genet; 2022 Jun; 264-265():60-65. PubMed ID: 35397254
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
Takashima Y; Kawaguchi A; Iwadate Y; Hondoh H; Fukai J; Kajiwara K; Hayano A; Yamanaka R
PLoS One; 2019; 14(1):e0210400. PubMed ID: 30615673
[TBL] [Abstract] [Full Text] [Related]
3. Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies.
Duhoux FP; Ameye G; Lambot V; Herens C; Lambert F; Raynaud S; Wlodarska I; Michaux L; Roche-Lestienne C; Labis E; Taviaux S; Chapiro E; Nguyen-Khac F; Struski S; Dobbelstein S; Dastugue N; Lippert E; Speleman F; Van Roy N; De Weer A; Rack K; Talmant P; Richebourg S; Mugneret F; Tigaud I; Mozziconacci MJ; Laibe S; Nadal N; Terré C; Libouton JM; Decottignies A; Vikkula M; Poirel HA; ;
PLoS One; 2011; 6(10):e26311. PubMed ID: 22039459
[TBL] [Abstract] [Full Text] [Related]
